VOLUME
61 2000 NUMBER 8
Brainstorms
547 Paying Attention to Your Acetylcholine, Part 1: Structural
Organization of Nicotinic Receptors. Stephen M. Stahl
[PDF]
Original Articles
549 Clinical Factors Associated With Treatment Noncompliance
in Euthymic Bipolar Patients. Francesc Colom, Eduard Vieta,
Anabel Martinez-Aran, Maria Reinares, Antonio Benabarre, and
Cristobal Gasto
[Abstract]
[PDF]
556 Is Melatonin Treatment Effective for Tardive Dyskinesia? Eyal
Shamir, Yoram Barak, Igor Plopsky, Nava Zisapel, Avner Elizur,
and Abraham Weizman
[Abstract]
[PDF]
559 A Double-Blind Comparison of Sertraline and Fluoxetine in
Depressed Elderly Outpatients. Paul A. Newhouse, K. Ranga Rama
Krishnan, P. Murali Doraiswamy, Ellen M. Richter, Evan D. Batzar,
and Cathryn M. Clary
[Abstract]
[PDF]
569 Pisa Syndrome (Pleurothotonus): Report of a Multicenter
Drug Safety Surveillance Project. Susanne Stubner, Frank
Padberg, Renate Grohmann, Harald Hampel, Matthias Hollweg, Hanns
Hippius, Hans-Jurgen Moller, and Eckart Ruther
[Abstract]
[PDF]
575 An Open-Label Trial of St. John's Wort (Hypericum
perforatum) in Obsessive-Compulsive Disorder. Leslie vH.
Taylor and Kenneth A. Kobak
[Abstract]
[PDF]
579 Predictors of Response to Sertraline Treatment of Severe
Premenstrual Syndromes. Ellen W. Freeman, Steven J.
Sondheimer, Marcia Polansky, and Beatriz Garcia-Espagna
[Abstract]
[PDF]
585 Clinical and Biological Findings in a Case With 48-Hour
Bipolar Ultrarapid Cycling Before and During Valproate Treatment.
Georg Juckel, Ulrich Hegerl, Paraskevi Mavrogiorgou, Jurgen
Gallinat, Torsten Mager, Peter Tigges, Stefan Dresel, Andreas
Schroter, Gabriele Stotz, Ingeborg Meller, Waldemar Greil, and
Hans-Jurgen Moller
[Abstract]
[PDF]
594 Fluvoxamine Reduces the Clozapine Dosage Needed in
Refractory Schizophrenic Patients. Mong-Liang Lu, Hsien-Yuan
Lane, Kun-Po Chen, Michael W. Jann, Muh-Hwan Su, and Wen-Ho Chang
[Abstract]
[PDF]
Academic Highlights
609 The Role of Mirtazapine in the Pharmacotherapy of
Depression.
[PDF]
CME Article 617
618 Predictors of the Development of Phobic Avoidance. David
A. Katerndahl
[Abstract]
[PDF]
Letters to the Editor
600 Venlafaxine and Vivid Dreaming. Daniele F. Zullino and
Francoise Riquier
[PDF]
600 Risperidone Metabolism and the Impact of Being a
Cytochrome P450 2D6 Ultrarapid Metabolizer. Cuneyt Guzey,
Trond Aamo, and Olav Spigset
[PDF]
601 Olanzapine-Induced Urinary Incontinence: Treatment With
Ephedrine. Lance T. Vernon, Matthew A. Fuller, Helen Hattab,
and Kathleen M. Varnes
[PDF]
602 Possible Connection Between Panic Disorder and Epilepsy. Jeffrey
B. Weilburg
[PDF]
- Reply by Peter P. Roy-Byrne
602 A Possible Case of Quetiapine Withdrawal Syndrome. Christian C. Thurstone and Peter Alahi
[PDF]
Book Reviews 604
Information for authors
see July 2000, pages 542544 or our Web site at http://www.psychiatrist.com/author.htm